Tag: <span>Lung cancer</span>

Home / Lung cancer
New immunotherapy targeting tumor macrophages to tackle lung cancer
Post

New immunotherapy targeting tumor macrophages to tackle lung cancer

by Germans Trias i Pujol Research Institute RImAb modifies the intratumoral myeloid cell compartment in a mouse model of LLC. a) Myeloid cell gating classification using the expression of surface markers CD45, CD11b, Ly6C, Ly6G, and MHCII. b) Percentage of CD45+CD11b+Ly6ChiLy6Ghi neutrophil population. c) Percentage of CD45+CD11b+Ly6C+Ly6Glo myeloid cell subset. d) Percentage of CD45+CD11b+Ly6CloMHCIIlo, CD45+CD11b+Ly6CloMHCIIhi, CD45+CD11b+Ly6ChiMHCIIlo and CD45+CD11b+Ly6ChiMHCIIhi myeloid cell subsets....

Quitting smoking early linked with improved survival rates for people diagnosed with lung cancer
Post

Quitting smoking early linked with improved survival rates for people diagnosed with lung cancer

by Harvard T.H. Chan School of Public Health Credit: Pixabay/CC0 Public Domain Quitting smoking early was associated with higher survival rates following a lung cancer diagnosis, according to a new study led by researchers at Harvard T.H. Chan School of Public Health. Compared to those who never smoked and were being treated for non-small cell lung...

New CAR T-cell strategy highly effective against small cell lung cancer in preclinical study
Post

New CAR T-cell strategy highly effective against small cell lung cancer in preclinical study

by Roswell Park Comprehensive Cancer Center Credit: Pixabay/CC0 Public Domain A new approach to chimeric antigen receptor T-cell (CAR T) therapy has shown great promise against small cell lung cancer (SCLC) in a preclinical study. The findings cover new ground in our understanding of how CAR T can be employed against solid-tumor cancers, and provide...

Post

New Clues to How Air Pollution Fuels Lung Cancer in Nonsmokers

Megan Brooks April 14, 2023 Air pollution may promote the growth of lung cancer in people who have never smoked by activating normally inactive cells in the lung that harbor cancer-causing mutations, new research indicates. “This work adds to our understanding of the mechanism by which air pollutants promote the earliest stages of lung cancer, particularly in...

Post

New tool to predict people’s risk of developing lung cancer within the next ten years

By Jane Icke, University of Nottingham Researchers at the University of Nottingham have helped to develop a new tool called “CanPredict,” which is able to identify the people most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and, most importantly, lives. Featured...

Lung cancer: New drug combination reduces tumors in animal study
Post

Lung cancer: New drug combination reduces tumors in animal study

Share on Pinterest Image credt: Bjarte Rettedal/Getty Images. Lung cancer is the second most common form of cancer worldwide. Each year, around 2 million people receive a lung cancer diagnosis, and 1.8 million people die of the disease. There are two types of lung cancer — small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC)...

Why lung cancer doesn’t respond well to immunotherapy
Post

Why lung cancer doesn’t respond well to immunotherapy

Anne Trafton | MIT News Office Publication Date: February 2, 2023 PRESS INQUIRIES Caption: A new MIT study explains why dendritic cells (green) in lymph nodes that drain from the lungs fail to stimulate killer T cells (white) to attack lung tumors.Credits: Courtesy of the researchers Immunotherapy — drug treatment that stimulates the immune system...

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer
Post

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

by Yale University DFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by seventh edition staging per the protocol (full analysis set). Tick marks indicate censored data. An HR < 1 favors osimertinib. DFS, disease-free survival; HR, hazard ratio;...

Post

AI TOOL PREDICTS RISK OF LUNG CANCER

Lung cancer is the leading cause of cancer death in the United States and around the world and low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and 80 years old who have a significant history of smoking or currently smoke. Lung cancer screening with LDCT has been shown to reduce deaths from...